Skip to main content

Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests Workshop Summary (2014) / Chapter Skim
Currently Skimming:

References
Pages 55-56

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 55...
... 2011. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: A total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation ­ tatuss for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC]
Read the entire page →
From page 56...
... 2012. A methods comparison analysis of the Roche cobas 4800 BRAF V600 mutation test and the Qiagen BRAF RGQ PCR kit on melanoma specimens with challenging attributes.
Read the entire page →

Key Terms

  • van krieken
  • drug discovery
  • external quality
  • companion diagnostic
  • reviews drug

  • nature reviews
  • molecular pathology
  • lung carcinoma
  • cell lung
  • factor receptor

  • targeted therapy
  • diagnostic test
  • methods comparison
  • pcr kit
  • qiagen braf

  • cancer therapy
  • assessment scheme
  • braf inhibitor
  • detecting kras
  • growth factor

  • metastatic melanoma
  • mutation test
  • roche cobas
  • diagnostic devices
  • rgq pcr

  • french laboratories
  • colorectal cancer
  • clinical utility
  • assessment programs
  • analytic performance


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.